<DOC>
	<DOCNO>NCT00361699</DOCNO>
	<brief_summary>Inhibition 3-hydroxy-3-methylglutaryl-coenzyme A ( HMG-CoA ) reductase play role prevent recurrent vascular event ischemic heart disease patient , whose mechanism consist reduction serum lipid level also anti-inflammatory effect . Serum high sensitive CRP know predictor cardiovascular event independent conventional risk factor . The present substudy examine whether pleiotrophic effect HMG-CoA reductase inhibitor ( statin ) decrease high sensitive CRP would observe post-ischemic stroke patient already register J-STARS , relationship value high sensitive CRP recurrence stroke .</brief_summary>
	<brief_title>hsCRP Japan Statin Treatment Against Recurrent Stroke ( J-STARS hsCRP )</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>Ischemic stroke except cardiogenic embolism , 1 month 3 year onset Hyperlipidemia total cholesterol level 180240mg/dl without prescription statin within previous 30 day Able visit outpatient department Informed consent form fill patient . Ischemic stroke determine cause accord TOAST classification Ischemic heart disease necessary use statin Hemorrhagic disorder Platelet count &lt; =100,000/ul within 3 month prior study start Alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) &gt; = 100IU/L within 3 month prior study start Serum creatinine &gt; =2.0mg/dl within 3 month prior study start A scheduled operation The presence malignant disorder</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>stroke</keyword>
	<keyword>brain ischemia</keyword>
	<keyword>cerebrovascular accident</keyword>
	<keyword>statin</keyword>
	<keyword>hydroxymethylglutaryl-CoA reductase inhibitor</keyword>
	<keyword>cholesterol</keyword>
	<keyword>hypercholesterolemia</keyword>
	<keyword>hyperlipidemia</keyword>
	<keyword>multicenter study</keyword>
	<keyword>prospective study</keyword>
	<keyword>endpoint determination</keyword>
	<keyword>randomize controlled trial</keyword>
	<keyword>recurrence</keyword>
	<keyword>pravastatin</keyword>
	<keyword>c-reactive Protein</keyword>
</DOC>